Replies to post #121905 on Biotech Values

[DewDiligence]

Obviousness/double patenting 0%
Non-infringement 10%
Indefiniteness 10%
Inequitable conduct 80%

The four arguments in the patent case are not mutually exclusive, and hence there is no reason why the four probabilities should sum to 100% (as yours do).

[DewDiligence]

do u have the link to [a] message which discusses why the claim "copolymer of lower molecular weight is less toxic" is obvious?

No one has addressed this directly, as far as I can recall. zipjet argues in #msg-56326587 that, if the Judge thinks Teva has engaged in abusive double-patenting, she will find a way to rule against Teva in some manner.